Cyteir Therapeutics, Inc. (CYT) Social Stream
CYTEIR THERAPEUTICS INC (CYT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CYT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-19 | 4 | $40 | $23 | $31.5 | $1.66 | 1797.59% |
| 2022-01-31 | 5 | $40 | $14 | $26.75 | $1.66 | 1511.45% |
| 2022-02-07 | 5 | $40 | $14 | $24.6 | $1.66 | 1381.93% |
| 2022-03-17 | 5 | $30 | $14 | $20.6 | $1.66 | 1140.96% |
| 2022-04-26 | 5 | $30 | $14 | $19.8 | $1.66 | 1092.77% |
| 2022-05-06 | 5 | $20 | $14 | $17.2 | $1.66 | 936.14% |
| 2022-05-10 | 5 | $19 | $14 | $16.6 | $1.66 | 900% |
| 2022-06-17 | 5 | $17 | $5 | $13.8 | $1.66 | 731.33% |
| 2022-08-08 | 4 | $17 | $5 | $13.25 | $1.66 | 698.19% |
| 2022-08-09 | 4 | $17 | $5 | $12.25 | $1.66 | 637.95% |
| 2022-08-13 | 4 | $14 | $5 | $10.666 | $1.66 | 542.53% |
| 2022-08-15 | 4 | $14 | $4 | $10.333 | $1.66 | 522.47% |
| 2022-09-17 | 4 | $13 | $4 | $7 | $1.66 | 321.69% |
| 2022-11-11 | 4 | $8 | $4 | $5.333 | $1.66 | 221.27% |
| 2023-01-27 | 4 | $4 | $3 | $3.666 | $1.66 | 120.84% |
| 2023-01-30 | 4 | $4 | $2 | $3 | $1.66 | 80.72% |
| 2023-02-08 | 4 | $3 | $2 | $2.333 | $1.66 | 40.54% |
The Trend in the Analyst Price Target
Over the past 40 weeks, CYT's average price target has gone down $14.87.
CYT reports an average of 389.18% for its upside potential over the past 46 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-06 | 5 | 20 | 14 | 17.200 | 1.90 | 805.26% |
| 2022-05-27 | 5 | 17 | 5 | 13.800 | 2.03 | 579.8% |
| 2022-06-17 | 3 | 17 | 5 | 13.250 | 2.07 | 540.1% |
| 2022-08-08 | 4 | 17 | 5 | 13.250 | 2.58 | 413.57% |
| 2022-08-13 | 4 | 14 | 5 | 10.666 | 2.48 | 330.08% |
CYT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.67 | 1 | 0 | 2 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
CYT's average broker recommendation rating worsened by 1.75 over the prior 35 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- CYTEIR THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 1704.42% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, CYTEIR THERAPEUTICS INC's average analyst price target is higher than 323.93% of them.
- In the context of all US stocks, CYTEIR THERAPEUTICS INC's number of analysts covering the stock is higher than 343.84% of them.
- CYTEIR THERAPEUTICS INC's variance in analysts' estimates is lower than -1270.31% of stocks in the small market cap category.
In the Pharmaceutical Products industry, GHRS, AVTE, and RLYB are the three stocks most similar to CYTEIR THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding CYT using the data that counts. Try POWR Ratings for free.